U.S. pharma big copyright scrapped two experimental weight loss supplements very last year—a after-everyday capsule, lotiglipron, because of elevated liver enzymes and also a twice-everyday pill, danuglipron, due to powerful Uncomfortable side effects—but CEO Albert Bourla has claimed the company is set to “play and earn” during the being o